INDICATIONS AND GUIDELINES FOR THE USE OF HEMATOPOIETIC GROWTH-FACTORS

被引:35
作者
GOODNOUGH, LT
ANDERSON, KC
KURTZ, S
LANE, TA
PISCIOTTO, PT
SAYERS, MH
SILBERSTEIN, LE
机构
[1] HARVARD UNIV, SCH MED, BOSTON, MA 02125 USA
[2] DANA FARBER CANC INST, BLOOD COMPONENT LAB, BOSTON, MA 02125 USA
[3] LAHEY CLIN FDN, DEPT LAB MED, BURLINGTON, MA 01805 USA
[4] UNIV CALIF SAN DIEGO, SCH MED, DEPT PATHOL, LA JOLLA, CA 92093 USA
[5] UNIV CONNECTICUT, CTR HLTH, MED LAB, FARMINGTON, CT 06030 USA
[6] UNIV CONNECTICUT, CTR HLTH, BLOOD BANK HEMATOL, FARMINGTON, CT 06030 USA
[7] UNIV WASHINGTON, SCH MED, DEPT MED, DIV HEMATOL, SEATTLE, WA 98104 USA
[8] PUGET SOUND BLOOD CTR, SEATTLE, WA 98104 USA
[9] UNIV PENN, BLOOD BANK, PHILADELPHIA, PA 19104 USA
[10] UNIV PENN, SCH MED, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1046/j.1537-2995.1993.331194082388.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:944 / 959
页数:16
相关论文
共 135 条
[31]   DRUG-THERAPY - ERYTHROPOIETIN [J].
ERSLEV, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1339-1344
[32]   TREATMENT OF THE ANEMIA OF PROGRESSIVE RENAL-FAILURE WITH RECOMBINANT HUMAN ERYTHROPOIETIN [J].
ESCHBACH, JW ;
KELLY, MR ;
HALEY, NR ;
ABELS, RI ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :158-163
[33]   CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].
ESCHBACH, JW ;
EGRIE, JC ;
DOWNING, MR ;
BROWNE, JK ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78
[34]   RECOMBINANT HUMAN ERYTHROPOIETIN IN ANEMIC PATIENTS WITH END-STAGE RENAL-DISEASE - RESULTS OF A PHASE-III MULTICENTER CLINICAL-TRIAL [J].
ESCHBACH, JW ;
ABDULHADI, MH ;
BROWNE, JK ;
DELANO, BG ;
DOWNING, MR ;
EGRIE, JC ;
EVANS, RW ;
FRIEDMAN, EA ;
GRABER, SE ;
HALEY, NR ;
KORBET, S ;
KRANTZ, SB ;
LUNDIN, AP ;
NISSENSON, AR ;
OGDEN, DA ;
PAGANINI, EP ;
RADER, B ;
RUTSKY, EA ;
STIVELMAN, J ;
STONE, WJ ;
TESCHAN, P ;
VANSTONE, JC ;
VANWYCK, DB ;
ZUCKERMAN, K ;
ADAMSON, JW .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (12) :992-1000
[35]  
EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825
[36]  
FAITHFULL NS, 1992, ADV EXP MED BIOL, V317, P55
[37]   EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA AND ASSOCIATED MORBIDITY DUE TO CHEMOTHERAPY FOR TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
SCHER, H ;
STERNBERG, C ;
WONG, G ;
GROUS, J ;
YAGODA, A ;
FAIN, K ;
MOORE, MAS ;
CLARKSON, B ;
OETTGEN, HF ;
ALTON, K ;
WELTE, K ;
SOUZA, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22) :1414-1422
[38]   PHASE-I STUDY OF GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS WITH TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM [J].
GABRILOVE, JL ;
JAKUBOWSKI, A ;
FAIN, K ;
GROUS, J ;
SCHER, H ;
STERNBERG, C ;
YAGODA, A ;
CLARKSON, B ;
BONILLA, MA ;
OETTGEN, HF ;
ALTON, K ;
BOONE, T ;
ALTROCK, B ;
WELTE, K ;
SOUZA, L .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) :1454-1461
[39]   MOLECULAR PHYSIOLOGY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [J].
GASSON, JC .
BLOOD, 1991, 77 (06) :1131-1145
[40]   RAPID AND COMPLETE HEMATOPOIETIC RECONSTITUTION FOLLOWING COMBINED TRANSPLANTATION OF AUTOLOGOUS BLOOD AND BONE-MARROW CELLS - A CHANGING-ROLE FOR HIGH-DOSE CHEMO-RADIOTHERAPY [J].
GIANNI, AM ;
BREGNI, M ;
SIENA, S ;
VILLA, S ;
SCIORELLI, GA ;
RAVAGNANI, F ;
PELLEGRIS, G ;
BONADONNA, G .
HEMATOLOGICAL ONCOLOGY, 1989, 7 (02) :139-148